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1. Introduction
Increased free radical formation and altered redox state are fundamentally important in
autoimmune diseases pathogenesis. Free radicals are mainly derived from oxygen (reactive
oxygen species/ROS) and nitrogen (reactive nitrogen species/RNS) in mitochondria, cellular
membranes, and the endoplasmic reticulum membrane as physiological responses to a variety
of internal and external stress. These free radicals play both beneficial and deleterious roles in
our body’s defense system [1]. ROS/RNS are beneficial to our body at low/moderate concen‐
trations via activation of redox-sensitive signaling pathways, phagocytosis of infected cells,
induction of mitogenic responses for wound healing, and clearance of abnormal or aging cells
as a part of an important surveillance mechanism [2-4].
Autophagy is a persistent homeostatic process in which certain cellular components are
engulfed by autophagosomes, and are subsequently degraded in order to produce energy, or
preserve viability and homeostasis. Autophagy breaks down compromised cellular compo‐
nents, such as damaged organelles and aggregated proteins, whose deposition within cells can
lead to toxic effects resulting in destruction of tissues, organisms, and biological systems [5].
Alterations in autophagic cycle rate (flux), which initiates with formation of phagophore and
terminates with degradation of autophagosome cargo after its fusion with lysosome, are
generally observed in response to stress [6]. In most cases, autophagy primarily serves an
adaptive role to protect organisms against diverse pathologies, including infections, cancer,
neurodegeneration, aging, and heart disease. However, in certain experimental settings,
autophagy may be deleterious [7]. Evidence from genetic, cell biology and lupus animal model
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studies suggests a pivotal role of autophagy in mediating the development of systemic lupus
erythematosus (SLE) [8]. The current chapter will focus on the following areas: (i) molecular
mechanism(s) by which ROS/RNS generate; (ii) redox signaling and altered autophagic flux
rates; (iii) the role of autophagy as a cell death progression or survival mechanism in response
to oxidative stress; and (iv) modulation of autophagy in antioxidant response relative to
autoimmune disease. Attention is specifically focused on understanding the molecular basis
of events by which autophagy is fine tuned by oxidation/reduction events in autoimmune
disease, especially SLE. Understanding the intricate relationships between oxidative stress
with both apoptosis and autophagy in SLE pathogenesis could be critical in elucidating key
pathogenic mechanisms, possibly leading to novel interventions for clinical disease manage‐
ment.
2. Reactive Oxygen Species (ROS)
Reactive oxygen species (ROS) is a general term for chemical species which are generated from
incomplete oxygen reduction. These are short lived molecules formed as a natural byproduct
of normal cellular metabolism and have dual role; deleterious and beneficial effect in our body.
ROS comprises several oxygen ion radicals such as superoxide anion radical (O2-.), peroxy
radical (ROO-), extremely reactive hydroxyl radical (.OH), peroxide (hydrogen peroxide
(H2O2), singlet oxygen (1O2), and perhydroxyl radical (HO2.). Sources and modes of action of
various reactive species are shown in Table 1 Beneficial role of ROS occur at low to moderate
concentration that can be demonstrated by several important role of ROS in cell signaling and
in defense against infectious agents and induction of a mitogenic response and immune
functions.
When the ROS productions are not scavenged sufficiently by antioxidant system, it causes
oxidative stress and shows harmful effect. These dangerous reactive species are formed by (1)
enzymes such as nicotinamide adenine dinucleotide phosphate (NADPH) [9] or nitric oxide
synthase [10], (2) non-enzymatic reactions through the mitochondrial electron transport chain
[11], or (3) reduced transition metals [12]. ROS can also interact with nitric oxide (NO), whose
expression is usually accompanied by inflammatory lesions. The product of NO synthases
results in conversion of NO to various reactive nitrogen species (RNS.), including nitrosonium
cation (NO+), nitroxyl anion (NO-), and peroxynitrite (ONOO.) (Table 1).
Reactive species Sources Modes of action
Super oxide (SO)
NADPH oxidase
Xanthine oxidase
Complex I/Complex III (mitochondria)
5-lipoxygenase, Cyclooxygenase
Uncoupled nitric oxide synthase
Oxidative stress
Redox signaling
Hydrogen peroxide (H2O2) Peroxisomes Redox signaling
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Reactive species Sources Modes of action
Super oxide dismutase Oxidative stress
Hydroxyl radical (OH) Fenton reactionHaber-Weiss reaction Oxidative stress
Hypochlorous acid (HOCL) Myeloperoxidase (MPO) ChlorinationOxidative stress
Nitric oxide (NO) Nitric oxide synthase Nitrosylation of metal centersRedox signaling
Peroxynitrite
(ONOO-) Reaction between NO and SO
Nitration, oxidation
Oxidative stress
Nitrogen dioxide
radical (NO2)
Reaction between NO and O2
Nitration, oxidation
Oxidative stress
Dinitrogen trioxide
(N2O3)
Reaction between NO and NO2
Nitrosation
Nitrosative stress
Table 1. List of critical reactive oxygen and nitrogen species, their sources, and modes of action.
3. Sources of oxygen radicals and their scavengers
Reactive oxygen species mainly originate from mitochondria and blood compartment,
including lymphocytes from SLE patients (Table 1). ROS show hyperpolarization of mito‐
chondria and activated T lymphocytes [13, 14]. We and others have shown an increased
production of ROS or diminished levels of intracellular reduced glutathione in various blood
compartments (RBC, lymphocytes) from SLE patients [15, 16]. Beside these important source
of ROS, these reactive oxygen species are also produced other sources such as NADPH oxidase
(NOX enzyme) in activated phagocytes [9], and minor amount from endothelial cells, macro‐
phage and polymononuclear cells [16-18], lysosome (myeloperoxidase undergoes a complex
array of redox transformations and produces HOCl), and microsomes [19, 20]. Hydrogen
peroxide is formed through the dismutation of O2-⋅ catalyzed by enzyme superoxide dismu‐
tase, and is also produced via action of several other oxidase enzymes (e.g., amino acid
oxidases) (Figure 1). Beside the role of ROS in cell damage, it is also involved in inflammation
generation by activation of nuclear transcription factor NF-kB, a master pathway of inflam‐
mation generation. Once, the NF-kB is activated it leads to upregulation of pro-inflammatory
cytokines and leukocyte adhesion molecules.
The most harmful ROS are hydroxyl radicals, OH⋅– and O2⋅–. Superoxide ion is converted into
stable non-radical hydrogen peroxide by SOD enzyme which is then reduced by following 3
mechanisms. In a detoxification mechanism, catalase and glutathione peroxidase convert
H2O2 to H2O + O2, this is considered as a detoxification mechanism. In the next mechanism,
H2O2 is converted by myeloperoxidase (MPO) in neutrophils to hypochlorous acid (HOCl).
This appears to be a mechanism for a physiological toxic agent, since HOCl is a strong oxidant
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that acts as a bactericidal agent in phagocytic cells. Reaction of HOCl with H2O2 yields singlet
oxygen (1O2) and water. The biological significance of singlet oxygen is unclear. In the last
mechanism, H2O2 is converted in a spontaneous reaction catalyzed by Fe2+ (Fenton reaction)
to the highly reactive hydroxyl radical (⋅OH). As the hydroxyl radical cannot be removed
without causing oxidative damage, it reacts rapidly with biological molecules such as lipid,
protein and DNA, triggering severe consequences in SLE pathogenesis [21-24].
4. Mechanism of oxidative damage
Reactive oxygen species, specifically the hydroxyl radical, respond with lipid layers and
produces receptive aldehydes, including malondialdehyde and 4-hydroxy-2-nonenal (HNE),
in three phage responses. It can "spread" oxidative damage through flow in SLE patients [25].
In the start stage an essential receptive radical concentrates a hydrogen iota from a methylene
gathering to begin peroxidation. These outcomes in the development of a conjugated diene,
leaving an unpaired electron on the carbon. Carbon-focused unsaturated fat radicals consoli‐
date with sub-atomic oxygen in the proliferation stage, yielding profoundly receptive peroxyl
radicals that respond with an alternate lipid particle to structure hydroperoxides. Peroxyl
radicals are fit for creating new unsaturated fat radicals, bringing about a radical chain
response. The course of lipid peroxidation bring about a mixed bag of unsafe final items
including conjugated dienes, isoprostanes, 4-hydroxy-2-nonenal (HNE), HNE-altered pro‐
teins, malondialdehyde (MDA), MDA-adjusted proteins, protein-bound acrolein and
oxHDL,which are associated with SLE disease activity [26-28]. In addition to the involvement
of ROS in lipid peroxidation, it can modify both structure and function of proteins in SLE
patients [21, 29]. Metal-catalyzed protein oxidation brings about expansion of carbonyl
gatherings, cross-connecting, or discontinuity of proteins. Lipid (peroxidation) aldehydes can
respond with sulfhydryl (cysteine) or essential amino acids (histidine, lysine). Essentially,
adjustment of individual nucleotide bases, single-strand breaks and cross-connecting are
regular impacts of ROS on nucleic acids. All these communications of ROS with protein, lipid
and nucleic corrosive prompts the development of adducts items which are exceedingly
immunogenic and are perceived as an outside molecule to our body, which may be included
in arrangement of pathogenic auto-immune response in SLE [30, 31].
5. Antioxidant defense system
The impact of ROS is restricted by the presence of various regulatory systems in aerobic
organisms to maintain redox homeostasis. A comparatively large number of compounds
possess some measurement of antioxidant activities. They keep up a harmony between the
generation and scavenger of ROS, and shield the cell from oxidative damage [32, 33]. Antiox‐
idant enzymes comprise SOD (superoxide dismutase), CAT (catalase) and glutathione related
enzymes; GPx (glutathione peroxidase), GR (glutathione reductase) and GST (Glutathione S-
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transferase), while non-enzymatic scavengers include vitamins E, C and A and thiol containing
compounds such as glutathione [34].
Reduced glutathione (L-γ-glutamyl-L-cysteinylglycine) is the most prevalent cellular thiol and
the most abundant low molecular weight peptide present in all cells [35]. GSH has an amaz‐
ingly essential role as a reductant in the very oxidizing environment of the erythrocyte. GSH
levels in human tissues ordinarily run from 0.1 to 10 mM, and are most gathered in the liver
(upto 10 mM), spleen, kidneys, lens, erythrocytes and leucocytes [36].]. In cell, more than 90%
of the total glutathione pool is in the reduced form (GSH) and less than 10% exists in the
oxidized form (GSSG). Reduced form of glutathione is required for many critical cellular
processes and plays a cardinal role in cell maintenance and regulation of the thiol-redox [37].
Thus the ratio of GSH/GSSG is a significant marker for characterizing oxidative anxiety.
Changes in this ratio relate with disease activity in SLE patients [15, 29]. Cellular GSH levels
affect T helper cell maturation [38], T cell proliferation [39], and susceptibility to ROS secreted
by inflammatory cells. Additionally, many correlations exist between immune system
dysfunction and alterations in GSH levels in the cells of SLE patients. We and others have
reported that GSH depletion in antigen presenting cells inhibits Th1-related cytokine produc‐
tion like IFN-γ and IL-12, which supports Th2- mediated humoral immune response in SLE
patients [39]. Protection against oxidative damage is normally afforded by replenishing
intracellular reduced glutathione through an antioxidant supplement of glutathione precur‐
sors N-acetylcysteine (NAC). Evidence from SLE patients and lupus prone mice supports the
role of glutathione as antioxidant therapy to diminish oxidative stress and severity of disease.
In (NZB × NZW) F1 lupus-prone mice NAC treatment prevented the decline of glutathione,
including GSSG ratios, reduced autoantibody production, development of nephritis, and
prolonged survival [40]. Two pilot studies of NAC treatment in SLE patients, Tewthanom (40
SLE patients) and Perl (36 SLE patients), showed that NAC treatment is effective in reversing
glutathione depletion and improving disease activity and fatigue in SLE patients [16, 41]. These
studies demonstrated that intracellular depletion displays an increased in oxidative stress and
replenishment of intracellular glutathione may diminish disease activity in SLE patients.
Superoxide dismutase is a metalloprotein, thought to be the first line of resistance against free
radicals. It catalyzes the dismutation of superoxide radical into oxygen and hydrogen peroxide
[42]. If not rummaged successfully, superoxide radicals might specifically inactivate a few
proteins like CAT and GPx, which are expected to take out hydrogen peroxide from intracel‐
lular medium [43]. This enzyme is found in 3 forms in human are: SOD1 located in the
cytoplasm, SOD2 in the mitochondria, and extracellular SOD3 [44]. While SOD1 is dimeric [42],
SOD2 and SOD3 are tetrameric [45, 46]. SOD1 and SOD3 contain copper and zinc, while SOD2
has manganese in its reactive center. Several groups reported decreased SOD activity and
formation of auto-antibodies against SOD in SLE patients [47-49]. Antibodies against SOD are
reported to have a role in the inactivation of SOD enzyme during increase oxidative state are
responsible to deleterious effect in SLE patients.
Catalase is generally present in peroxisomes (80%) and cytosol (20%) of all oxygen consuming
cells and responsible for managing harmful hydrogen peroxide produced inside cells. It
catalyzes hydrogen peroxide to water and oxygen without production of free radicals [50, 51].
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CAT is most elevated in the liver, kidney and erythrocytes and low in connective tissues [52].
In the most organs (e.g., liver, kidney), catalase is found as particle found (mitochondria and
peroxisomes) where it exists in soluble state in erythrocytes. Under the physiological condition,
H2O2 is catalyzed by glutathione peroxidase (high affinity for H2O2)while at high concentration
H2O2 is removed by catalase enzyme [12]. The important of catalase enzyme in the SLE patients
is well documented in SLE patients. The polymorphism catalase enzyme (-330CC genotype)
showed remarkable association with several disease activities such as thrombocytopenia, renal
manifestations, as well as production of anti-nRNP and anti-Scl-70 antibodies in SLE patients
[53]. An elegant study by Mansour et al. reported that elevated levels of auto-antibodies against
catalase in excessive oxidative stress state in SLE patients are associated with disease activity
[54]. In two different studies they demonstrated that SLE patients have increased levels of IgG
antibodies (Ab) against CAT in SLE patients compared to control subjects [54, 55].
Glutathione peroxidase belongs to the selenoprotein family and is one of the most important
anti-oxidant enzymes in human. It catalyses hydroperoxides and protects biomembranes and
cell structures from oxidative damage. [56]. This enzyme accomplishes these protections
through utilization of glutathione as a reducing substrate and converting hydroperoxides to
free hydrogen peroxide to water [57]. In animals studies the important of this enzyme can be
illustrated by following evidences. Glutathione peroxidase knockout mice have abnormal
cardiac mitochondria and associated with increase mitochondrial ROS production and
oxidative mtDNA damage.
In SLE patients, decrease activity of glutathione peroxidase enzyme has been associated with
increase in oxidized redox environment in cell [47]. Since, glutathione peroxidase enzyme is
also required for maintaining intracellular glutathione levels, which is key antioxidant and
control oxidative stress and involved in regulating several immune functions such as apoptosis
[58]and cytokine network [38] in SLE pathogenesis.
6. Oxidative-stress and autophagy
Excessive oxidative stress and altered redox signaling are most commonly known to be
involved in cell death signaling cascades. However, their role in regulation of autophagy is
largely unknown in autoimmune diseases. Autophagy is a persistent homeostatic process in
which certain cell components are engulfed by autophagosomes and, subsequently degraded
in order to produce energy or preserve cellular viability and homeostasis [59]. Autophagy
breaks down compromised cellular components, such as damaged organelles and aggregated
proteins. Deposition of these components within cells can lead to toxicity, resulting in
destruction of tissues, organisms, and biological systems [60]. Elevated ROS causing autoph‐
agy promotes either cell survival or cell death, the fate of which depends upon the severity of
stress occurring with a particular disease.
Several studies have shown that ROS accumulation in the cell activates the autophagy process.
For example, a mutation in an antioxidative superoxide dismutase (SOD1) gene modulates
autophagy. Reports from different laboratories have described autophagy activation in
Autoimmunity - Pathogenesis, Clinical Aspects and Therapy of Specific Autoimmune Diseases6
transgenic mice expressing mutant SOD1 [61, 62]. In the first report, SOD1G93A transgenic mice
displayed inhibition of mTOR and accumulation of lipid-conjugated LC3, the mammalian
homologue of Atg8 [62]. A recent report showed that mutant SOD1 interacts directly with p62
(also called SQSTM1), an LC3 binding partner known to target protein aggregates for auto‐
phagic degradation. Indeed, this interaction is proposed to mediate autophagic degradation
of mutant SOD1 [63]. Ruth Scherz-Shouval's group has suggested two major ROS (H2O2 and
O2-.) as the main regulators of autophagy [64]. H2O2 is a striking contender for signaling because
it is comparatively stable and long- lived as compared to other ROS species. Its neutral ionic
state enables it to exit the mitochondria with ease. It has been implicated as a signaling molecule
in various signal transduction pathways, including autophagy [65]. Indeed, ATG4, an essential
protease in the autophagic pathway, has been identified as a direct target for oxidation by
H2O2 during starvation [66]. Other studies report autophagy activation in response to exoge‐
nous H2O2 treatment [67] In most cases, this treatment leads to oxidative stress and mitochon‐
drial damage, which induce autophagy. Taken together, this evidence supports the vital role
of oxidative stress in the induction of autophagy.
7. Redox signaling and autophagy
Redox signaling involves targeted modification by reactive species through a chemically
reversible reaction. The reaction of ROS/RNS with the target molecule acts as an on-off switch
signal. Oxidative damage in response to oxidative stress leads to irreversible oxidation of
proteins lipids and nucleic acids [68]. However, since amino-acid residues in proteins, fatty
acids in lipids and nucleic acid bases have different susceptibility to oxidative stress. ‘‘Mild’’
oxidative stress appears to provide selectivity for a specifically targeted molecule and may
constitute a signaling mechanism even when an irreversible modification is produced [69].
Oxidative damage can be repaired to a certain extent, as evident in the diverse array of DNA
repair systems. In addition, oxidized proteins can be effectively degraded and recycled by both
proteasome and autophagy systems. Proteasomal degradation of oxidatively modified
proteins requires protein unfolding; thus, only mildly oxidized proteins are suitable protea‐
some substrates. During oxidative stress, the resulting cellular response and outcome is likely
to involve both redox signaling and oxidative damage, whose contribution will depend on the
concentration and nature of the ROS/RNS involved [70]. NAC decreased both cellular ROS
production and autophagy, implicating redox thiol signaling as an important regulator of
autophagy.
8. Autophagy as cell death progression or survival in response to oxidative
stress
Similar to autophagy, ROS/RNS formation has been linked to the regulation of both pro-
survival and cell death pathways (Figure 1). To generalize, basal levels of ROS/RNS formation
and those induced by growth factor receptor activation are essential for maintaining appro‐
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priate cellular homeostasis and mediate cell proliferation by redox signaling [71]. ROS/RNS-
mediated redox signaling also regulates survival-promoting adaptive responses to cellular
stress. Redox signaling, generally occurs in the absence of an overall imbalance of pro-oxidants
and antioxidants [71]. In contrast, when antioxidant defenses are surpassed by ROS/RNS
formation, and oxidative damage is not repaired by endogenous mechanisms, oxidative stress
leads to cell death. However, although oxidative damage to proteins, lipids, and nucleic acids
is associated with activation of programmed cell death, both pro-apoptotic and pro-survival
signaling proteins are modulated by specific reversible oxidative modifications [71, 72].
Figure 1. Oxidative stress, redox signaling, and autophagy: cell death versus survival. (1) Basal or physiological lev‐
els of ROS/RNS play an important homeostatic role regulating signal transduction involved in proliferation and sur‐
vival. (2) In contrast, when antioxidant defenses are surpassed by ROS/RNS formation and oxidative damage is not
repaired by endogenous mechanisms, oxidative stress leads to cell death. (3) Under these pathological conditions, ‘‘ex‐
cessive’’ autophagy might promote cell death through degradation of important components within the cell. In addi‐
tion, (4) lysosomal membrane permeabilization induced by stress can also contribute to cell death. However, (5)
‘‘mild’’ oxidative stress can act as a signaling mechanism leading to adaptive stress responses. Oxidative damage can
be repaired to a certain extent and oxidized biomolecules, such as proteins, can be degraded and recycled by distinct
processes, including autophagy. During oxidative stress the resulting cellular response and outcome is likely to in‐
volve both redox signaling and oxidative damage, whose contribution will depend on the concentration and nature of
the ROS/RNS involved, the duration of the stress response, and cell type or gender. A clear distinction between both
oxidative stress and redox signaling is hard to define.
9. Modulation of autophagy by antioxidant in autoimmune disease
There is a lack of literature on the role of redox signaling by oxidative cysteine modification
in autophagy. Cysteines can act as post-translational modification sites which are utilized for
targeting proteins to membranes and/or influence protein activity, localization, and/or
protein–protein interactions [73]. In response to ROS or RNS, redox-sensitive cysteines
undergo reversible and irreversible thiol modifications. Almost all physiological oxidants react
with thiols [74]. O2 - and peroxides (H2O2, and ONOO-) mediate one- and two-electron
oxidation of protein cysteines respectively, leading to formation of reactive intermediates
protein sulfenic acids (PSOH) and protein thiyl radicals (PS), respectively. PSOH can lead to
formation of additional oxidative modifications that act as signaling events regulating protein
function. The reaction of PSOH with either another protein cysteine or GSH will generate a
disulfide bond or a glutathionylated residue (PSSG). PSSG is considered as a protective
modification against irreversible cysteine oxidation. PSOH can undergo further reaction with
H2O2 and irreversibly generate protein sulfinic (PSO2H) and sulfonic (PSO3H) acids. The
reversible covalent adduction of a nitroso group (NO) to a protein cysteine is referred to as
protein nitros(yl)ation (PSNO). PSNO occurs by endogenous NO-mediated nitros(yl)ating
agents such as dinitrogen trioxide (N2O3) or by transition metal-catalyzed addition of NO. The
transfer of NO groups between PSNO and GSNO (transnitros[yl]ation) is one of the major
mechanisms mediating PSNO. GSNO is formed during oxidation of NO in the presence of
GSH, or as a by-product from the oxidation of GSH by ONOO- [75].
Reversible conjugation of the Atg8 family of proteins to autophagosomal membrane is a
hallmark event in the autophagic process. All Atg8 homologues (including LC3) are substrates
for the Atg4 family of cysteine proteases. Atg4s cleave Atg8 near the C-terminus downstream
of a conserved glycine, enabling its conjugation to PE. Atg4 further cleaves Atg8 (LC3)-PE,
releasing it from the membrane. Thus, after initial cleavage of Atg8(LC3)-like proteins, Atg4
must be inactivated to ensure the conjugation of Atg8 (LC3) to the autophagosomal membrane.
After the autophagosome fuses with the lysosome, Atg4 is re-activated in order to dilapidate
and recycle Atg8 (LC3). Recently, it was revealed that upon starvation, increased generation
of mitochondrial H2O2 oxidizes and inactivates Atg4 after the initial cleavage of LC3, ensuring
structural integrity of the mature form [66]. A number of signaling molecules regulating
apoptosis are reported to be regulated by oxidative cysteine modifications. For example,
glutathionylation (PSSG) of nuclear factor-kappa B (NF-kB) and caspases, have been reported
to regulate apoptotic cell death [76]. Similarly, caspases and the anti-apoptotic Bcl-2 protein
have been shown to be nitros(yl)ated (PSNO) under basal conditions in human lung epithelial
cancer cells, and their denitros(yl)ation is necessitated for their activation during apoptosis
[77]. Both apoptosis and autophagy are simultaneously activated by the distinct stressors.
Cross-talk between both the signaling pathways has been evidenced primarily by (1) interac‐
tion of Bcl-2 or Bcl-xl with Beclin-1, which inhibits autophagy; and (2) cleavage/degradation
of Beclin-1 by caspases [78]. Thus, both glutathionylation and nitrosylation might exert
regulatory roles in autophagy by indirect regulation of Bcl-2 and caspase activity [77]. Protein
nitros(yl)ation exert inhibitory effects on autophagy. Nitros(yl)ation and inhibition of JNK1
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and IKKb signaling pathways are also reported to inhibit autophagy by increased Bcl-2-
Beclin-1 interaction and decreased AMPK phosphorylation [79].
AMPK is a key regulator of metabolism, particularly glycolysis. By regulation of ULK1 and
mTORC1 complexes, AMPK has been demonstrated to regulate autophagy [80]. In HEK293
cells, H2O2 was recently demonstrated to oxidize cysteine residues of α-(Cys299 and Cys304)
and β-subunits of AMPK via glutathionylation, with a concomitant increase in its kinase
activity. Hypoxia is reported to activate AMPK via mitochondrial ROS formation independent
from the AMP/ATP ratio in mitochondrial DNA-deficient cells [81]. Ataxia-telangiectasia
mutated (ATM) protein kinase is activated by DNA double strand breaks (DSBs) to initiate
DNA damage response. Cells lacking ATM are also hypersensitive to insults other than DSBs,
particularly oxidative stress. Oxidation of ATM directly induces its activation in the absence
of DNA damage via a disulfide-cross-linking dimerization [82]. Activation of ATM by
oxidative stress or genotoxic damage was recently reported to activate AMPK and the tuberous
sclerosis complex 2 (TSC2), which in turn participates in energy sensing and growth factor
signaling to repress the kinase mTOR in the mTORC1 complex [83]. Studies regarding
mechanisms by which ROS, redox signaling, and autophagy regulate autoimmune disease
progression is a new research field that could provide pivotal information toward under‐
standing and development of therapeutic to manage the disease.
10. Modulation of autophagy in systemic lupus erythematosus
SLE is an autoimmune disorder characterized by the auto-antibodies directed against self-
antigens, immune complex formation and immune deregulation, resulting in damage to any
organ, including kidneys, skin, blood cells, and nervous system [84]. It is a multifactorial
disease and its etiology comprises hormonal, environmental and genetic background. While
mechanisms underlying this systemic autoimmune response remain largely unknown, several
vital studies show that uncontrolled reactive oxygen generation and defect in regulation of
antioxidant system are, in part, crucial factors for the pathogenesis of SLE [85]. The uncon‐
trolled oxidative species generations are speculated to be involved in the production, expan‐
sion of antibody flares [86] and various clinical features in SLE [87]. Oxidative damage
mediated by ROS results in formation of deleterious byproducts, such as aldehydic products,
and leads to development of adducts with proteins. The consequence of this effect makes them
highly immunogenic, thus inducing pathogenic antibodies in SLE [88]. In the last 2 decades,
there has been substantial progress in understanding the mechanism of oxidative stress in SLE
pathogenesis (Figure 2) and the level of intracellular glutathione has been regarded as a
checkpoint of oxidative stress [1]. Altered signal transduction pathways, mTOR is activated
by relative depletion of glutathione and supplementation of N-acetyl cysteine (NAC), a
precursor of glutathione. mTOR replenishes intracellular glutathione, inhibits mTOR signaling
and diminished oxidative stress mediated damage in SLE [89]. Glutathione is a key cellular
component, a small tri-peptide constructed from three amino acids (glycine, glutamic acid and
cysteine), known to be a powerful antioxidant. The main function of glutathione is to protect
the cell and mitochondria from oxidative damage, indicating its role in energy utilization.
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Management of disease through supplement of NAC and rapamycin has shown promise as a
therapy for SLE patients. Administration of rapamycin decreased production of autoantibod‐
ies, glomerular deposits of immunoglobulins, development of proteinuria, and prolonged
survival in murine SLE. Interestingly, autophagy is regulated by mTOR pathway, and mTOR
is activated by relative depletion of glutathione. Thus, redox signaling may provide a link
between altered autophagy and depletion of glutathione and autophagy regulation by
replenishment of intracellular glutathione may have a therapeutic intervention for disease
management [90].
Figure 2. Oxidative stress involvement in the pathogenesis of SLE. MDA, malondialdehyde; 4-HNE, 4-hydroxynone‐
nal; GSH, glutathione; MHP, mitochondrial hyperpolarization; NO, nitric oxide; O2 -, superoxide; ONOO-, peroxyni‐
trite.
It has been shown that changes in the intracellular redox environment of in cells, through
oxidative stress, have been reported to be critical for cellular immune dysfunction [48],
activation of apoptotic enzymes, and apoptosis [15]. Decreased intracellular glutathione levels
in the various blood components, including total lymphocytes and its subsets (CD4, CD8 T
cell), are strongly associated with disease severity and linked to increase Th1/Th2 cytokine
imbalance and lymphocyte apoptosis in SLE patients [49]. Similarly, Tewthanom et al. [41]
reported that administration of NAC may be beneficial for patients with mild SLE in terms of
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decreasing lipid peroxidation. Lai et al. demonstrated that GSH regulates elevation of mito‐
chondrial transmembrane potential (Δψm) or mitochondrial hyperpolarization (MHP), which
in turn activates mTOR in lupus T cells [91]. mTOR skews cell death signal processing,
modulates T-cell differentiation, and, in particular, inhibits development of CD4+/CD25+/
Foxp3+ regulatory T cells which are deficient in patients with active SLE. These studies are
important as they suggest the blockade of mTOR with rapamycin and NAC improves lupus
disease activity [89, 91].
In recent years, perturbation in autophagy has been implicated in a number of diseases,
including SLE [8]. Towns et al. [92] found that serum factors, likely autoantibodies, purified
from SLE patients were able to induce autophagy in neuroblastoma cell lines, providing a
further link between autophagy and SLE. Several other groups have reported activated
autophagy pathway in T and B lymphocytes as a mechanism for survival of autoreactive T
and B lymphocytes. Inhibition of autophagy by blocking mTOR signaling has been suggested
as a novel target for treatment in this disease. Importantly, Lai et. al. has shown that blockade
of mTOR with supplementation of NAC reversing glutathione depletion and improving
disease activity and fatigue in SLE patients [91]. NAC treatment promotes expansion of
CD4+CD25+FOXP3+ T cell subsets and inhibits anti-DNA antibody production. Indeed, NAC
reversed expansion of CD4–CD8– T cells, which exhibited the most prominent mTOR activation
before treatment with NAC, and may be responsible for promoting anti-DNA autoantibody
production by B cells. They showed that NAC acts as a sensor of ∆Ψm, mTOR governs T-cell
signaling events implicated in pathogenesis [91]. Since, activation of autophagy has been
considered to be principally regulated by the mTOR pathway, supplementation of NAC block
mTOR signaling in SLE patients.
11. Conclusion
The autophagic process is highly regulated and is stimulated by several factors including
oxidative stress. Cell death occurs when over production of ROS/NOS fails to be corrected by
antioxidant machinery, activate autophagy, which in turn removes damaged components, or
when damage exceeds a certain threshold. However, whether autophagy leads to a pro-
survival response or cell death depends on the situation and severity of oxidative stress
occurring in a particular pathologic setting. Evidence from genetics, cell biology and lupus
animal model studies suggests a pivotal role of autophagy in mediating occurrence and
development of SLE. Importantly, autophagy is regulated by the mTOR pathway, and mTOR
is activated by relative depletion of glutathione. This suggests that redox signaling may
provide a link between altered redox signaling and autophagy in SLE. Therefore it will be
interesting to study the effect of therapeutic supplements of NAC on autophagy in animal
models of lupus and in SLE patients. Such controlled clinical studies encourage exploration of
the therapeutic potential of NAC, which might prove to provide an inexpensive and significant
alternative therapy for SLE.
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